BIOWKS — Bio-Works Technologies AB Income Statement
0.000.00%
Last trade - 00:00- SEK100.18m
- SEK65.90m
- SEK25.47m
Annual income statement for Bio-Works Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.23 | 21.9 | 41.3 | 43.9 | 25.5 |
| Cost of Revenue | |||||
| Gross Profit | 4.22 | 18.6 | 28.8 | 26.8 | -2.77 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 52 | 31.8 | 87.4 | 100 | 63.5 |
| Operating Profit | -44.7 | -9.84 | -46.1 | -56.3 | -38 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -45 | -9.37 | -44.7 | -54.7 | -37.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -45 | -12.9 | -45 | -56.8 | -37.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -45 | -12.9 | -45 | -56.8 | -37.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -45 | -12.9 | -45 | -56.8 | -37.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.07 | -0.296 | -0.915 | -1.12 | -0.709 |
| Dividends per Share |